CleveMed
CleveMed, founded in 1990 in Cleveland, Ohio, designs FDA-cleared portable home sleep testing devices, direct-to-patient fulfillment services, and cloud-based sleep study management software, serving sleep labs, primary care, cardiology, and corporate wellness customers. Since April 2025 it has operated as a subsidiary of Beacon Biosignals, integrating HST infrastructure with AI-driven EEG-based brain monitoring.
- Company typePrivate
- Founded1990
- HeadquartersCleveland, United States
- Headcount11–50
- GTM typeB2B
- OfferingHardware or Manufacturing
What CleveMed does
CleveMed (legal name Cleveland Medical Devices Inc., now operating as Beacon Bio Dx, LLC dba CleveMed) is a Cleveland, Ohio-based medical device company founded in 1990 that develops, manufactures, and distributes wireless portable home sleep testing (HST) hardware, direct-to-patient fulfillment services, and cloud-based sleep study management software. Its product platform centers on the SleepView Monitor, an FDA-cleared AASM Type III seven-channel portable sleep apnea testing device that wirelessly transfers physiological data to the HIPAA-compliant SleepView Web Portal, complemented by SleepView Direct, a mail-order fulfillment service that ships devices directly to patient homes for telemedicine-enabled testing. The company also offers legacy portable monitors (Sapphire, SleepScout), an IDcheck biometric verification add-on, a published SleepView Web Portal API for partner integration, and registered SleepView, Crystal PSG, and eCrystal PSG trademarks.
CleveMed generates revenue through a mix of hardware unit sales and rentals (SleepView Monitor, Sapphire, SleepScout), recurring web portal subscription fees for cloud-based data management and scoring, professional services tied to direct-to-patient fulfillment and end-to-end HST workflow support, and channel revenue flowing through its exclusive U.S. distribution partner Roscoe Medical. Pricing is quote-based for providers, with home sleep testing delivered at less than a quarter of the cost of in-lab polysomnography. The company distributes through direct enterprise sales to sleep labs and large health systems, the Roscoe Medical dealer network, the Welltrinsic sleep network, a Premier Inc. GPO agreement, and a self-serve web portal. Target buyers span sleep specialists, primary care practices and nurse practitioners, cardiology groups, corporate wellness programs, retail clinics, and ENTs/dental sleep medicine providers. The product portfolio is backed by over 20 issued and 27 pending US and foreign patents, ISO 13485 and ISO 27001 certifications, ACHC accreditation, and CE marking.
On April 21, 2025, CleveMed was acquired by Beacon Biosignals, a neurotechnology company specializing in at-home EEG and AI-driven brain monitoring, and was fully integrated under the Beacon brand by mid-2026. The combined platform extends CleveMed's HST infrastructure with AI-driven EEG scoring algorithms, expanding data capture to include airflow, respiratory effort, and oxygen saturation alongside direct brain activity measurement, and supports pharma data-licensing programs such as the disclosed multi-year partnership with Takeda. Under Beacon ownership, CleveMed's leadership (President and CEO Hani Kayyali, founder and Chairman Robert Schmidt) continues to operate the HST business while serving as the HST infrastructure layer within a broader neurodiagnostic and neurobiomarker platform.
CleveMed firmographics
Firmographics- Name
- CleveMed
- Legal name
- Cleveland Medical Devices Inc.
- Website
- https://clevemed.com
- Company type
- Private
- Founded year
- 1990
- Operating status
- Acquired
- Headcount range
- 11–50 employees
- Short description
- CleveMed, founded in 1990 in Cleveland, Ohio, designs FDA-cleared portable home sleep testing devices, direct-to-patient fulfillment services, and cloud-based sleep study management software, serving sleep labs, primary care, cardiology, and corporate wellness customers. Since April 2025 it has operated as a subsidiary of Beacon Biosignals, integrating HST infrastructure with AI-driven EEG-based brain monitoring.
- Ownership category
- akta.pro rank
CleveMed industry classification
Industry- Product category
- Home Sleep Testing Devices
- NAICS
- Home Health Care Services (6216), Home Health Equipment Rental (532283)
- SIC
- Services-Health Services (8000)
- akta.pro primary industry
- Sleep Diagnostics & Monitoring (PSG/Home Sleep Testing, Actigraphy) (HLAHAGAB)
- akta.pro secondary industry
- Pulmonology & Sleep Medicine Telemedicine Platforms (HLALAGAF)
Keywords
Where CleveMed is headquartered
LocationHeadquarters
- HQ city
- Cleveland
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
CleveMed business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Technology or R&D, Operations, Marketing or Sales, Personnel, Supply Chain, Infrastructure
Revenue model
- Home Sleep Testing Devices: Sale/rental of portable sleep monitoring devices (SleepView Monitor, Sapphire, SleepScout) to healthcare providers including sleep labs, primary care practices, and cardiology groups.
- Sleep Testing Services: Fulfillment services including device mailing to patients' homes, data management, scoring, and interpretation services through the SleepView Web Portal. Provides end-to-end home sleep testing workflow solutions.
- Software/SaaS Platform: Web-based software subscriptions for data management, secured online access, and cloud-based portal services for sleep study management.
- Distribution/Channel Revenue: Revenue through exclusive distribution partnership with Roscoe Medical for SleepView Monitor sales in the United States.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Unit Pricing | One time/ perpetual license | SleepView Monitor device sales |
| Other | Monthly | SleepView Direct fulfillment service |
| Subscription | Monthly | Web Portal subscription |
Go-to-market motion2 records
Distribution channels5 records
Marketing channels7 records
CleveMed product offering
Product offeringCore offering
CleveMed designs, manufactures, and distributes FDA-cleared portable home sleep apnea testing (HST) devices and related fulfillment and software services. Its flagship SleepView Monitor is a Type III portable HST device that meets American Academy of Sleep Medicine channel guidelines, complemented by SleepView Direct (a mail-order, direct-to-patient fulfillment service) and the SleepView Web Portal (a HIPAA-compliant cloud platform for study scheduling, scoring, interpretation, and reporting). The vertically integrated offering enables physicians and health systems to deliver cost-effective sleep diagnostics outside of traditional sleep labs.
Product overview
CleveMed provides an integrated home sleep testing ecosystem centered on the SleepView product family. The core SleepView Monitor is a Type III portable home sleep apnea testing device meeting AASM channel guidelines, while SleepView Direct provides mail-order fulfillment delivering devices directly to patients. The SleepView Web Portal enables web-based data management, scheduling, and clinic workflow integration. The platform incorporates automated scoring algorithms for respiratory event detection and sleep time estimation, with manual over-read by registered polysomnographic technologists. Legacy products include Sapphire and SleepScout portable sleep monitors. Following acquisition by Beacon Biosignals in April 2025, CleveMed operates as part of Beacon Biosignals with full brand integration completed in 2026, expanding to include respiratory and oxygen saturation data alongside EEG-based brain monitoring.
Differentiator
Problem solved
Functional benefit
Brands
- SleepView: Home sleep testing device and associated web portal for portable sleep apnea diagnosis
- SleepView Monitor
- SleepView Direct
- SleepView Web Portal
Products and services
- SleepView Monitor
Quantifiable outcome
- Sleep study capacity expansion without capital expenditure for healthcare providers
- +2 more outcomes
Companies that use CleveMed
Customer profileNamed customers5 records
Segments5 records
Ideal customer profiles4 records
CleveMed technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- Yes
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability5 records
Feature6 records
CleveMed partnerships and signals
Strategic signalPartnerships
Nine partnerships are on record, tiered core, flagship and minor.
- TakedacoreMulti-year partnership with Takeda (up to $109 million in data license fees and development milestones) using CleveMed/Beacon's at-home EEG headband and cloud AI platform for narcolepsy diagnostics and neurobiomarker development. Takeda is strategic investor in Beacon Biosignals.
- Beacon BiosignalsflagshipBeacon Biosignals acquired CleveMed in strategic transaction combining Beacon's AI-driven EEG and brain monitoring with CleveMed's home sleep testing technology. Integration creates most advanced EEG-based home sleep testing platform.
- Sleep Care OnlineminorSleep Care Online combines telemedicine and home sleep apnea testing with board-certified physicians and sleep coaches. Integration with CleveMed's SleepView technology.
- WelltrinsiccorePartnership with Welltrinsic sleep network to offer home sleep apnea testing using CleveMed's technologies nationwide. Welltrinsic represents a large group of sleep centers and physicians.
- Crowne/CareHereminorPartnership expansion of sleep apnea pilot program at on-site health clinics across Florida to 7 sites using CleveMed technologies.
- Premier, Inc.coreGroup purchasing agreement for Sleep Diagnostic Services with Premier, Inc. Effective June 1, 2014, allowing Premier members access to special pricing and terms.
- Ancillary Medical Solutions (AMS)minorAMS selected CleveMed's SleepView as exclusive device for Home Sleep Testing. AMS has nearly 200 sales territories across the country for market education.
- Cardiology Consultants of Philadelphia (CCP)core5-year pioneering collaboration with CCP, one of the largest cardiology practices in the U.S., and local sleep centers for specialty practice accreditation. CleveMed technology enabled integrated cardiac-sleep care programs.
- Roscoe MedicalcoreStrategic partnership making Roscoe Medical the exclusive U.S. distributor of SleepView Monitor. Roscoe Medical, manufacturer and distributor of home medical equipment, serves customers throughout the U.S., Canada, and Puerto Rico through their dealer network.
Scale indicators5 records
Recent moves7 records
Expansion highlights6 records
CleveMed competitors and assessment
Company assessmentDirect peers
- Nox Medical:
- Itamar Medical (ZOLL Itamar): WatchPAT is a wrist-based, FDA-cleared Type III home sleep apnea test using peripheral arterial tonometry, competing head-to-head with SleepView in cardiology and primary care HST workflows; now part of ZOLL Medical, giving it stronger distribution than CleveMed.
Broad incumbents
- ResMed: Global leader in sleep apnea therapy (CPAP/APAP) that also sells home sleep testing devices such as ApneaLink Air and the recently acquired Verily/Alix partner ecosystem. Directly comparable to CleveMed as a competing HST device plus broader sleep franchise, but with vastly greater scale and a dominant therapy-installed base.
- Philips Respironics: Incumbent in sleep diagnostics and therapy, offering Alice NightOne home sleep testing devices plus the full Alice PSG in-lab line and DreamStation CPAP/APAP. Direct overlap with CleveMed's SleepView Type III HST and broader sleep lab channel.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
CleveMed social profiles
Digital presenceCleveMed compliance and trust
Trust signalCompliance4 records
CleveMed financial estimates
Financial estimateRevenue estimate
Valuation estimate
CleveMed leadership team
Management profileNumber of profiles
Profiles2 records
CleveMed funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
CleveMed M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about CleveMed
What does CleveMed do?
CleveMed designs, manufactures, and distributes FDA-cleared portable home sleep apnea testing (HST) devices and related fulfillment and software services. Its flagship SleepView Monitor is a Type III portable HST device that meets American Academy of Sleep Medicine channel guidelines, complemented by SleepView Direct (a mail-order, direct-to-patient fulfillment service) and the SleepView Web Portal (a HIPAA-compliant cloud platform for study scheduling, scoring, interpretation, and reporting). The vertically integrated offering enables physicians and health systems to deliver cost-effective sleep diagnostics outside of traditional sleep labs.
Is CleveMed a public or private company?
CleveMed is a private company. It is classified as corporate owned and is currently acquired.
When was CleveMed founded?
CleveMed was founded in 1990. It employs 11 to 50 people.
Where is CleveMed based?
CleveMed is headquartered in Cleveland, United States, in the North America region.
How does CleveMed make money?
Four revenue lines are on record. Home Sleep Testing Devices are the primary driver. The others are sleep Testing Services, software/SaaS Platform and distribution/Channel Revenue.
Who are CleveMed's main competitors?
Direct peers on record are Nox Medical and Itamar Medical (ZOLL Itamar). Broad incumbents are ResMed and Philips Respironics.
Does CleveMed have an API?
Yes. CleveMed released the SleepViewSM Web Portal API, enabling external developers and partners to integrate with CleveMed's home sleep testing platform. The API facilitates data exchange for scheduling studies, uploading monitor data, and accessing raw data for scoring and interpretation. Developer documentation is at www.clevemedsleepview.com.
What industry is CleveMed in?
CleveMed's product category is Home Sleep Testing Devices. Its primary akta.pro industry code is HLAHAGAB, Sleep Diagnostics & Monitoring (PSG/Home Sleep Testing, Actigraphy), with a secondary code of HLALAGAF, Pulmonology & Sleep Medicine Telemedicine Platforms. Its NAICS code is 6216 and its SIC code is 8000.